Needham raised the firm’s price target on iRhythm (IRTC) to $255 from $254 and keeps a Buy rating on the shares after its Q1 earnings beat. The company continues to see strong demand across the core business with building contribution from new channel initiatives helping drive solid margin improvement throughout the P&L, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- iRhythm price target lowered to $180 from $198 at Canaccord
- iRhythm: Strong Q1 Beat, Expanding Zio Adoption and Next-Gen Algorithm Catalyst Underpin Outperform Rating and 2026 Upside
- iRhythm reports Q1 adjusted EPS (35c), consensus (64c)
- iRhythm sees FY26 revenue $875M-$885M, consensus $876.16M
- 2 Under-the-Radar Wearable AI Stocks Analysts Are Bullish On
